Items tagged with Advocacy

Activism delivers unprecedented victories in TB testing and treatment access (post with simple image)

Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

Call for experts: WHO Civil Society Task Force on TB (2024-2025 mandate) (post with simple image)

The World Health Organization launches a call for experts to serve as members of the Civil Society Task Force on TB. Deadline to apply: 23 November 2023.

Call for nominations: Stop TB Partnership Community Award 2023 (post with simple image)

The Stop TB Partnership launches a call for nominations for the Community Award 2023 under the theme - Serving the most vulnerable: Increasing access to TB services for key and vulnerable populations. Deadline for nominations: 1 December 2023.

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB (post with simple image)

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

TB REACH Wave 11 now open for proposals (post with simple image)

The TB REACH Wave 11 call for proposals is focused on innovative approaches to integrate TB service delivery with lung health at the primary and community level of the health systems.

Let communities lead: #EndAIDS #EndTB (post with simple image)

1 December 2023 | Genev -- World AIDS Day 2023 this year focuses on unleashing the full potential of community leadership to enable the end of AIDS. People and communities affected by tuberculosis (TB) are critical stakeholders in ending both TB and HIV.

(post with simple image)

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Report: TB Research Funding Trends 2005-2022 (post with simple image)

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.